When choosing a CDMO to work on a project, there are a number of important areas to consider prior to making a selection. Often, the formulation experience within the group and the available equipment are main drivers for the selection process, with the cost, timeline, level of experience with what needs to be done in the project, analytical capabilities, and regulatory inspection track record of the site being important factors as well.
These additional areas should be examined as part of the due diligence process to ensure the drug product CDMO selected is the best fit for the project. Further considerations include the phase of development the project is in, the clinical need for the product, and the sponsoring company’s overall objective.
These aspects, along with those covered in this white paper, should give a holistic view of the project and help to guide the selection of a CDMO that will be a good partner.
